Loss of Neuronal Imp Contributes to Seizure Behavior through Syndecan Function

We thank the members of the Link lab for critical reading of the manuscript. We thank Claude Desplan for providing the anti-Imp antibody used in this study. The monoclonal antibody Elav-9F8A9, developed by Gerald M. Rubin at Janelia Farm Research, Howard Hughes Medical Institute, was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at the Department of Biology, University of Iowa, Iowa City, IA 52242. We acknowledge the information provided by FlyBase (National Human Genome Research Institute Awards U41HG000739 and U24HG010859) using release FB2023_04. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. P.R.R. was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under Award Number T32HD007491 and the National Institutes of Health under Ruth L. Kirschstein National Research Service Award T32HG008962 from the National Human Genome Research Institute at the University of Utah. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. N.L. was funded in part by the National Institute of Allergy and Infectious Diseases Grants R56AI170857 and R01AI170857 and the University of Utah.